Clinical trial
Effects of Combined Sevoflurane and Nitrous Oxide Inhalation - 14
NCT00000262 · University of Chicago, Other · Completed
Key facts
| NCT number | NCT00000262 |
|---|---|
| Title | Effects of Combined Sevoflurane and Nitrous Oxide Inhalation - 14 |
| Official title | Effects of Combined Sevoflurane and Nitrous Oxide Inhalation |
| Lead sponsor | University of Chicago, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Opioid-Related Disorders, Substance-Related Disorders |
| Intervention type | Drug, Other |
| Interventions | 30% Nitrous oxide, 0.4% Sevoflurane, 0.2% sevoflurane, Placebo |
| Enrollment | 20 |
| Start date | Nov 1, 1996 |
| Primary completion | Feb 1, 1999 |
| Completion | Feb 1, 1999 |
| First posted | Sep 21, 1999 |
| Last update posted | May 27, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: